Showing results (811-820 of 4,513) with videos related to

Sort By:
Pageof 452
Future Oncology (London, England)|August 22, 2020
Decreased level of peripheral CD8+CD28+ T cells is associated with lymph node metastasis in patients with breast cancerYalun Li, Tianyi Qian, Hengqiang Zhao, et al.
Future Oncology (London, England)|July 21, 2020
Pediatric low grade focal brainstem glioma: outcomes of different treatment strategies and prognostic factorsCaroline Elmaraghi, Mai K Bishr, Amr G Mousa, et al.
Future Oncology (London, England)|July 18, 2020
FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with FGFR2 rearrangementsTanios S Bekaii-Saab, Juan W Valle, Eric Van Cutsem, et al.
Future Oncology (London, England)|March 31, 2021
Methylation patterns partition pancreatic cancer into distinct prognostic subtypesZhiming Zhao, Mengyang Li, Xianglong Tan, et al.
Future Oncology (London, England)|July 7, 2012
The significance of p53 isoform expression in serous ovarian cancerSetsuko K Chambers, Jesse D Martinez
Future Oncology (London, England)|July 7, 2012
Pharmacologic modulation strategies to reduce dose requirements of anticancer therapy while preserving clinical efficacyYing-Kiat Zee, Boon-Cher Goh, Soo-Chin Lee
Future Oncology (London, England)|March 12, 2015
Olaparib: an oral PARP-1 and PARP-2 inhibitor with promising activity in ovarian cancerCamille C Gunderson, Kathleen N Moore
Future Oncology (London, England)|March 12, 2015
A periodic table for cancerRichard J Epstein
Future Oncology (London, England)|March 12, 2015
An analysis of the therapeutic benefits of genotyping in pediatric hematopoietic stem cell transplantationFelicity A Wright, Mary Bebawy, Tracey A O'Brien
Future Oncology (London, England)|March 12, 2015
Current and future targeted therapies for non-small-cell lung cancers with aberrant EGF receptorsShanthi Kanthala, Sandeep Pallerla, Seetharama Jois
Pageof 452